The telomerase vaccine UV1 combined with ipilimumab and nivolumab versus ipilimumab and nivolumab in advanced melanoma (INITIUM): A randomized open-label phase 2 study
作者
Paul Lorigan,Theresa Medina,Marta Nyakas,Annemie Rutten,Lynn G. Feun,Charles Lance Cowey,Miranda Payne,Israr Hussain,Timothy M. Kuzel,Steven O’Day,Amna Sheri,Philip Friedlander,Satish Kumar,Vanja Sue Bergersen,Øivind Foss,Espen B. Ellingsen,Jens Bjørheim,Oliver Bechter